Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | RMC-6236 |
Trade Name | |
Synonyms | RMC 6236|RMC6236 |
Drug Descriptions |
RMC-6236 forms a binary complex with CypA that prevents GTP-bound RAS from interacting with downstream effectors, potentially leading to anti-tumor activity (Cancer Res 2022;82(12_Suppl): Abstract nr 3597). |
DrugClasses | RAS Inhibitor (Pan) 10 |
CAS Registry Number | NA |
NCIT ID | C188048 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Pembrolizumab + Pemetrexed Disodium + RMC-6236 | Carboplatin Pembrolizumab Pemetrexed Disodium RMC-6236 | 0 | 1 |
Cisplatin + Pembrolizumab + Pemetrexed Disodium + RMC-6236 | Cisplatin Pembrolizumab Pemetrexed Disodium RMC-6236 | 0 | 1 |
HRX-0233 + RMC-6236 | HRX-0233 RMC-6236 | 0 | 0 |
Pembrolizumab + RMC-6236 | Pembrolizumab RMC-6236 | 0 | 1 |
RMC-6236 | RMC-6236 | 0 | 1 |
RMC-6236 + RMC-6291 | RMC-6236 RMC-6291 | 0 | 1 |